Engerix-B
Executive Summary
SmithKline's genetically engineered hepatitis B vaccine receives regulatory approval in the U.K., West Germany and the Netherlands. Product is now officially registered and marketed in 21 countries, with applications pending in more than 60.
You may also be interested in...
Speculation Over Moderna Vaccine Deal With Tata, Wockhardt
Moderna is speculated to be in talks with Indian firms, including Wockhardt and a Tata group company, for manufacturing its COVID-19 vaccine. A deal in India could help the company meet its obligation to supply COVAX but Moderna is likely to choose its partner carefully.
QUOTED. 27 January 2021. Scott Whitaker.
Trade group AdvaMed should be consulted on how to implement the Defense Production Act to boost testing and PPE production, CEO Scott Whitaker said in a letter to President Biden.
Korean Biopharma IPOs Start Strong With Prestige
Following a successful offering by Prestige BioPharma in January, investors will keep their focus on another upcoming major listing by the SK Group's specialist vaccines arm SK Bioscience, which is likely to set the tone for the South Korean biopharma IPO market this year.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: